Search Results
6 protocol(s) meet the specified criteria
102483Open  
Non-Randomized, Open-Label, Phase II Study of Trametinib in Patients with Unresectable or Metastatic Epithelioid Hemangioendothelioma

103123Open  
Multicenter, Phase I, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, Efficacy, and Pharmacokinetics in Patients with Advanced Malignancies

105166Open  
Randomlzed Phase III Trial of TRC105 and Pazopanib versus Pazop Anib Alone in Patients with Advanced Angiosarcoma (TAPPAS)

76853Open  
Phase I/IB Study of MGCD516 in Patients with Advanced Solid Tumor Malignancies

81405Not Open *
Phase I/IIA Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PLX8394 in Patients with Advanced, Unresectable Solid Tumors

88956Open  
Phase I/II Trial of Pre-Operative Image Guided Intensity Modulated Proton Radiation Therapy (IMPT) with Simultaneously Integrated Boost to the High Risk Margin for Retroperitoneal Sarcomas (Phase II Only)